| Heading: |
Epilepsy: Drugs |
| Question ID: |
1817941 |
| UIN: |
63714 |
| House: |
Commons |
| Date tabled: |
2025-06-30 |
| Asking Member ID: |
4630 |
| Asking Member display name: |
Ben Lake
|
| Asking Member handle: |
BenMLake
|
| Asking Member Twitter reference: |
@BenMLake
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, with reference to the Independent Medicines and Medical Devices Safety Review report, published on 8 July 2020, if he will make an assessment of the potential merits of launching a public inquiry i |
| Is named day: |
true |
| Date of holding answer: |
2025-07-04 |
| Date answered: |
2025-07-10 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Everyone who has been harmed following use of anti-seizure medication has our deepest sympathies. We fully understand the importance of patient safety, which is a top priority for this government. It is vital we do all we can to stop harm from happening i... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |